Company Filing History:
19 out of 36 
15 out of 83 
4 out of 67 
Years Active: 1981-2014
Title: Innovations by Yendra Linnau in Plasma Protein Medicaments
Introduction
Yendra Linnau, located in Vienna, Austria, is a prolific inventor with an impressive portfolio of 39 patents. His work primarily focuses on advancements in the field of biomedicine, specifically in the development of plasma protein-containing medicaments. This article delves into his latest patents, career highlights, and collaborations with fellow professionals.
Latest Patents
Among Yendra's latest inventions, the first is a method for producing a plasma protein-containing medicament with reduced concentrations of citrate and metals. This innovative method allows for the preparation of a medicament from citrated plasma or from a citrate-containing plasma fraction, ensuring the final product is substantially free from unwanted metals.
Another significant patent is the method for producing a factor VIII/von Willebrand factor complex. This invention outlines a technique for generating a highly pure factor VIII:C/von Willebrand factor complex through chromatography in a cation exchanger, achieving at least 300 times the purity of the original plasma while maintaining a yield of at least 50% of the vital factors in relation to cryoprecipitates or similar plasma fractions.
Career Highlights
Throughout his career, Yendra Linnau has been affiliated with prominent companies such as Immuno Aktiengesellschaft für Chemisch-Medizinische Produkte and Immuno Aktiengesellschaft. His work in these organizations has significantly contributed to his expertise and innovations in the field of plasma medicine.
Collaborations
Yendra has worked alongside notable colleagues such as Johann J. Eibl and Otto Schwarz. These collaborations have fostered advancements in biopharmaceutical technologies and strengthened the impact of their combined research efforts.
Conclusion
Yendra Linnau stands out as a key innovator in the development of plasma protein-containing medicaments. His contributions through numerous patents and collaborations reflect his dedication to enhancing biomedicine. Through his patented methods, he continues to pave the way for advancements that can improve patient care and treatment outcomes.